Evaluation	evaluation	O	O	O	O
of	of	O	O	O	O
cardiac	cardiac	O	O	O	O
troponin	troponin	CHEMICALS	O	OTHERS	I
I	i	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
T	t	O	O	O	O
levels	levels	O	O	O	O
as	as	O	O	O	O
markers	markers	O	O	O	O
of	of	O	O	O	O
myocardial	myocardial	O	DISEASE	OTHERS	I
damage	damage	O	DISEASE	OTHERS	I
in	in	O	O	O	O
doxorubicin-induced	doxorubicin-induced	O	O	O	O
cardiomyopathy	cardiomyopathy	O	DISEASE	OTHERS	I
rats	rats	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
their	their	O	O	O	O
relationship	relationship	O	O	O	O
with	with	O	O	O	O
echocardiographic	echocardiographic	O	O	O	O
and	and	O	O	O	O
histological	histological	O	O	O	O
findings	findings	O	O	O	O
.	.	O	O	O	O

BACKGROUND	background	O	O	O	O
:	:	O	O	O	O
Cardiac	cardiac	O	O	O	O
troponins	troponins	O	O	O	O
I	i	O	O	O	O
(	(	O	O	O	O
cTnI	ctni	O	O	O	O
)	)	O	O	O	O
and	and	O	O	O	O
T	t	O	O	O	O
(	(	O	O	O	O
cTnT	ctnt	O	O	O	O
)	)	O	O	O	O
have	have	O	O	O	O
been	been	O	O	O	O
shown	shown	O	O	O	O
to	to	O	O	O	O
be	be	O	O	O	O
highly	highly	O	O	O	O
sensitive	sensitive	O	O	O	O
and	and	O	O	O	O
specific	specific	O	O	O	O
markers	markers	O	O	O	O
of	of	O	O	O	O
myocardial	myocardial	O	O	OTHERS	I
cell	cell	O	O	OTHERS	I
injury	injury	O	O	OTHERS	I
.	.	O	O	O	O

We	we	O	O	O	O
investigated	investigated	O	O	O	O
the	the	O	O	O	O
diagnostic	diagnostic	O	O	O	O
value	value	O	O	O	O
of	of	O	O	O	O
cTnI	ctni	O	O	O	O
and	and	O	O	O	O
cTnT	ctnt	O	O	O	O
for	for	O	O	O	O
the	the	O	O	O	O
diagnosis	diagnosis	O	O	O	O
of	of	O	O	O	O
myocardial	myocardial	O	DISEASE	OTHERS	I
damage	damage	O	DISEASE	OTHERS	I
in	in	O	O	O	O
a	a	O	O	O	O
rat	rat	O	O	O	O
model	model	O	O	O	O
of	of	O	O	O	O
doxorubicin	doxorubicin	CHEMICALS	O	OTHERS	I
(DOX)-induced	(dox)-induced	O	O	O	O
cardiomyopathy	cardiomyopathy	O	DISEASE	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
we	we	O	O	O	O
examined	examined	O	O	O	O
the	the	O	O	O	O
relationship	relationship	O	O	O	O
between	between	O	O	O	O
serial	serial	O	O	O	O
cTnI	ctni	O	O	O	O
and	and	O	O	O	O
cTnT	ctnt	O	O	O	O
with	with	O	O	O	O
the	the	O	O	O	O
development	development	O	O	O	O
of	of	O	O	O	O
cardiac	cardiac	O	O	OTHERS	I
disorders	disorders	O	O	OTHERS	I
monitored	monitored	O	O	O	O
by	by	O	O	O	O
echocardiography	echocardiography	O	O	O	O
and	and	O	O	O	O
histological	histological	O	O	O	O
examinations	examinations	O	O	O	O
in	in	O	O	O	O
this	this	O	O	O	O
model	model	O	O	O	O
.	.	O	O	O	O

METHODS	methods	O	O	O	O
:	:	O	O	O	O
Thirty-five	thirty-five	O	O	O	O
Wistar	wistar	O	O	O	O
rats	rats	O	O	O	O
were	were	O	O	O	O
given	given	O	O	O	O
1.5	1.5	O	O	O	O
mg/kg	mg/kg	O	O	O	O
DOX	dox	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
i.v	i.v	O	O	O	O
.	.	O	O	O	O
,	,	O	O	O	O
weekly	weekly	O	O	O	O
for	for	O	O	O	O
up	up	O	O	O	O
to	to	O	O	O	O
8	8	O	O	O	O
weeks	weeks	O	O	O	O
for	for	O	O	O	O
a	a	O	O	O	O
total	total	O	O	O	O
cumulative	cumulative	O	O	O	O
dose	dose	O	O	O	O
of	of	O	O	O	O
12	12	O	O	O	O
mg/kg	mg/kg	O	O	O	O
BW	bw	O	O	O	O
.	.	O	O	O	O

Ten	ten	O	O	O	O
rats	rats	O	O	O	O
received	received	O	O	O	O
saline	saline	O	O	O	O
as	as	O	O	O	O
a	a	O	O	O	O
control	control	O	O	O	O
group	group	O	O	O	O
.	.	O	O	O	O

cTnI	ctni	O	O	O	O
was	was	O	O	O	O
measured	measured	O	O	O	O
with	with	O	O	O	O
Access(R	access(r	O	O	O	O
)	)	O	O	O	O
(	(	O	O	O	O
ng/ml	ng/ml	O	O	O	O
)	)	O	O	O	O
and	and	O	O	O	O
a	a	O	O	O	O
research	research	O	O	O	O
immunoassay	immunoassay	O	O	O	O
(	(	O	O	O	O
pg/ml	pg/ml	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
compared	compared	O	O	O	O
with	with	O	O	O	O
cTnT	ctnt	O	O	O	O
,	,	O	O	O	O
CK-MB	ck-mb	O	O	O	O
mass	mass	O	O	O	O
and	and	O	O	O	O
CK	ck	O	O	O	O
.	.	O	O	O	O

By	by	O	O	O	O
using	using	O	O	O	O
transthoracic	transthoracic	O	O	O	O
echocardiography	echocardiography	O	O	O	O
,	,	O	O	O	O
anterior	anterior	O	O	O	O
and	and	O	O	O	O
posterior	posterior	O	O	O	O
wall	wall	O	O	O	O
thickness	thickness	O	O	O	O
,	,	O	O	O	O
LV	lv	O	O	OTHERS	I
diameters	diameters	O	O	O	O
and	and	O	O	O	O
LV	lv	O	O	OTHERS	I
fractional	fractional	O	O	O	O
shortening	shortening	O	O	O	O
(	(	O	O	O	O
FS	fs	O	O	O	O
)	)	O	O	O	O
were	were	O	O	O	O
measured	measured	O	O	O	O
in	in	O	O	O	O
all	all	O	O	O	O
rats	rats	O	O	O	O
before	before	O	O	O	O
DOX	dox	CHEMICALS	O	OTHERS	I
or	or	O	O	O	O
saline	saline	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
at	at	O	O	O	O
weeks	weeks	O	O	O	O
6	6	O	O	O	O
and	and	O	O	O	O
9	9	O	O	O	O
after	after	O	O	O	O
treatment	treatment	O	O	O	O
in	in	O	O	O	O
all	all	O	O	O	O
surviving	surviving	O	O	O	O
rats	rats	O	O	O	O
.	.	O	O	O	O

Histology	histology	O	O	O	O
was	was	O	O	O	O
performed	performed	O	O	O	O
in	in	O	O	O	O
DOX-rats	dox-rats	O	O	O	O
at	at	O	O	O	O
6	6	O	O	O	O
and	and	O	O	O	O
9	9	O	O	O	O
weeks	weeks	O	O	O	O
after	after	O	O	O	O
the	the	O	O	O	O
last	last	O	O	O	O
DOX	dox	CHEMICALS	O	OTHERS	I
dose	dose	O	O	O	O
and	and	O	O	O	O
in	in	O	O	O	O
all	all	O	O	O	O
controls	controls	O	O	O	O
.	.	O	O	O	O

RESULTS	results	O	O	O	O
:	:	O	O	O	O
Eighteen	eighteen	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
DOX	dox	CHEMICALS	O	OTHERS	I
rats	rats	O	O	O	O
died	died	O	O	O	O
prematurely	prematurely	O	O	O	O
of	of	O	O	O	O
general	general	O	O	O	O
toxicity	toxicity	O	DISEASE	OTHERS	I
during	during	O	O	O	O
the	the	O	O	O	O
9-week	9-week	O	O	O	O
period	period	O	O	O	O
.	.	O	O	O	O

End-diastolic	end-diastolic	O	O	O	O
(	(	O	O	O	O
ED	ed	O	O	O	O
)	)	O	O	O	O
and	and	O	O	O	O
end-systolic	end-systolic	O	O	O	O
(	(	O	O	O	O
ES	es	O	O	O	O
)	)	O	O	O	O
LV	lv	O	O	OTHERS	I
diameters/BW	diameters/bw	O	O	O	O
significantly	significantly	O	O	O	O
increased	increased	O	O	O	O
,	,	O	O	O	O
whereas	whereas	O	O	O	O
LV	lv	O	O	OTHERS	I
FS	fs	O	O	O	O
was	was	O	O	O	O
decreased	decreased	O	O	O	O
after	after	O	O	O	O
9	9	O	O	O	O
weeks	weeks	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
DOX	dox	CHEMICALS	O	OTHERS	I
group	group	O	O	O	O
(	(	O	O	O	O
p<0.001	p<0.001	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

These	these	O	O	O	O
parameters	parameters	O	O	O	O
remained	remained	O	O	O	O
unchanged	unchanged	O	O	O	O
in	in	O	O	O	O
controls	controls	O	O	O	O
.	.	O	O	O	O

Histological	histological	O	O	O	O
evaluation	evaluation	O	O	O	O
of	of	O	O	O	O
hearts	hearts	O	O	O	O
from	from	O	O	O	O
all	all	O	O	O	O
rats	rats	O	O	O	O
given	given	O	O	O	O
DOX	dox	CHEMICALS	O	OTHERS	I
revealed	revealed	O	O	O	O
significant	significant	O	O	O	O
slight	slight	O	O	O	O
degrees	degrees	O	O	O	O
of	of	O	O	O	O
perivascular	perivascular	O	O	O	O
and	and	O	O	O	O
interstitial	interstitial	O	O	OTHERS	I
fibrosis	fibrosis	O	DISEASE	OTHERS	I
.	.	O	O	O	O

In	in	O	O	O	O
7	7	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
18	18	O	O	O	O
rats	rats	O	O	O	O
,	,	O	O	O	O
degeneration	degeneration	O	O	O	O
and	and	O	O	O	O
myocyte	myocyte	O	O	O	O
vacuolisation	vacuolisation	O	O	O	O
were	were	O	O	O	O
found	found	O	O	O	O
.	.	O	O	O	O

Only	only	O	O	O	O
five	five	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
controls	controls	O	O	O	O
exhibited	exhibited	O	O	O	O
evidence	evidence	O	O	O	O
of	of	O	O	O	O
very	very	O	O	O	O
slight	slight	O	O	O	O
perivascular	perivascular	O	O	O	O
fibrosis	fibrosis	O	DISEASE	OTHERS	I
.	.	O	O	O	O

A	a	O	O	O	O
significant	significant	O	O	O	O
rise	rise	O	O	O	O
in	in	O	O	O	O
cTnT	ctnt	O	O	O	O
was	was	O	O	O	O
found	found	O	O	O	O
in	in	O	O	O	O
DOX	dox	CHEMICALS	O	OTHERS	I
rats	rats	O	O	O	O
after	after	O	O	O	O
cumulative	cumulative	O	O	O	O
doses	doses	O	O	O	O
of	of	O	O	O	O
7.5	7.5	O	O	O	O
and	and	O	O	O	O
12	12	O	O	O	O
mg/kg	mg/kg	O	O	O	O
in	in	O	O	O	O
comparison	comparison	O	O	O	O
with	with	O	O	O	O
baseline	baseline	O	O	O	O
(	(	O	O	O	O
p<0.05	p<0.05	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

cTnT	ctnt	O	O	O	O
found	found	O	O	O	O
in	in	O	O	O	O
rats	rats	O	O	O	O
after	after	O	O	O	O
12	12	O	O	O	O
mg/kg	mg/kg	O	O	O	O
were	were	O	O	O	O
significantly	significantly	O	O	O	O
greater	greater	O	O	O	O
than	than	O	O	O	O
that	that	O	O	O	O
found	found	O	O	O	O
after	after	O	O	O	O
7.5	7.5	O	O	O	O
mg/kg	mg/kg	O	O	O	O
DOX	dox	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Maximal	maximal	O	O	O	O
cTnI	ctni	O	O	O	O
(	(	O	O	O	O
pg/ml	pg/ml	O	O	O	O
)	)	O	O	O	O
and	and	O	O	O	O
cTnT	ctnt	O	O	O	O
levels	levels	O	O	O	O
were	were	O	O	O	O
significantly	significantly	O	O	O	O
increased	increased	O	O	O	O
in	in	O	O	O	O
DOX	dox	CHEMICALS	O	OTHERS	I
rats	rats	O	O	O	O
compared	compared	O	O	O	O
with	with	O	O	O	O
controls	controls	O	O	O	O
(	(	O	O	O	O
p=0.006	p=0.006	O	O	O	O
,	,	O	O	O	O
0.007	0.007	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

cTnI	ctni	O	O	O	O
(	(	O	O	O	O
ng/ml	ng/ml	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
CK-MB	ck-mb	O	O	O	O
mass	mass	O	O	O	O
and	and	O	O	O	O
CK	ck	O	O	O	O
remained	remained	O	O	O	O
unchanged	unchanged	O	O	O	O
in	in	O	O	O	O
DOX	dox	CHEMICALS	O	OTHERS	I
rats	rats	O	O	O	O
compared	compared	O	O	O	O
with	with	O	O	O	O
controls	controls	O	O	O	O
.	.	O	O	O	O

All	all	O	O	O	O
markers	markers	O	O	O	O
remained	remained	O	O	O	O
stable	stable	O	O	O	O
in	in	O	O	O	O
controls	controls	O	O	O	O
.	.	O	O	O	O

Analysis	analysis	O	O	O	O
of	of	O	O	O	O
data	data	O	O	O	O
revealed	revealed	O	O	O	O
a	a	O	O	O	O
significant	significant	O	O	O	O
correlation	correlation	O	O	O	O
between	between	O	O	O	O
maximal	maximal	O	O	O	O
cTnT	ctnt	O	O	O	O
and	and	O	O	O	O
ED	ed	O	O	O	O
and	and	O	O	O	O
ES	es	O	O	O	O
LV	lv	O	O	OTHERS	I
diameters/BW	diameters/bw	O	O	O	O
(	(	O	O	O	O
r=0.81	r=0.81	O	O	O	O
and	and	O	O	O	O
0.65	0.65	O	O	O	O
;	;	O	O	O	O
p<0.0001	p<0.0001	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

A	a	O	O	O	O
significant	significant	O	O	O	O
relationship	relationship	O	O	O	O
was	was	O	O	O	O
observed	observed	O	O	O	O
between	between	O	O	O	O
maximal	maximal	O	O	O	O
cTnT	ctnt	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
extent	extent	O	O	O	O
of	of	O	O	O	O
myocardial	myocardial	O	O	O	O
morphological	morphological	O	O	O	O
changes	changes	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
between	between	O	O	O	O
LV	lv	O	O	OTHERS	I
diameters/BW	diameters/bw	O	O	O	O
and	and	O	O	O	O
histological	histological	O	O	O	O
findings	findings	O	O	O	O
.	.	O	O	O	O

CONCLUSIONS	conclusions	O	O	O	O
:	:	O	O	O	O
Among	among	O	O	O	O
markers	markers	O	O	O	O
of	of	O	O	O	O
ischemic	ischemic	O	O	OTHERS	I
injury	injury	O	O	OTHERS	I
after	after	O	O	O	O
DOX	dox	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
rats	rats	O	O	O	O
,	,	O	O	O	O
cTnT	ctnt	O	O	O	O
showed	showed	O	O	O	O
the	the	O	O	O	O
greatest	greatest	O	O	O	O
ability	ability	O	O	O	O
to	to	O	O	O	O
detect	detect	O	O	O	O
myocardial	myocardial	O	DISEASE	OTHERS	I
damage	damage	O	DISEASE	OTHERS	I
assessed	assessed	O	O	O	O
by	by	O	O	O	O
echocardiographic	echocardiographic	O	O	O	O
detection	detection	O	O	O	O
and	and	O	O	O	O
histological	histological	O	O	O	O
changes	changes	O	O	O	O
.	.	O	O	O	O

Although	although	O	O	O	O
there	there	O	O	O	O
was	was	O	O	O	O
a	a	O	O	O	O
discrepancy	discrepancy	O	O	O	O
between	between	O	O	O	O
the	the	O	O	O	O
amount	amount	O	O	O	O
of	of	O	O	O	O
cTnI	ctni	O	O	O	O
and	and	O	O	O	O
cTnT	ctnt	O	O	O	O
after	after	O	O	O	O
DOX	dox	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
probably	probably	O	O	O	O
due	due	O	O	O	O
to	to	O	O	O	O
heterogeneity	heterogeneity	O	O	O	O
in	in	O	O	O	O
cross-reactivities	cross-reactivities	O	O	O	O
of	of	O	O	O	O
mAbs	mabs	O	O	O	O
to	to	O	O	O	O
various	various	O	O	O	O
cTnI	ctni	O	O	O	O
and	and	O	O	O	O
cTnT	ctnt	O	O	O	O
forms	forms	O	O	O	O
,	,	O	O	O	O
it	it	O	O	O	O
is	is	O	O	O	O
likely	likely	O	O	O	O
that	that	O	O	O	O
cTnT	ctnt	O	O	O	O
in	in	O	O	O	O
rats	rats	O	O	O	O
after	after	O	O	O	O
DOX	dox	CHEMICALS	O	OTHERS	I
indicates	indicates	O	O	O	O
cell	cell	O	O	O	O
damage	damage	O	O	O	O
determined	determined	O	O	O	O
by	by	O	O	O	O
the	the	O	O	O	O
magnitude	magnitude	O	O	O	O
of	of	O	O	O	O
injury	injury	O	O	O	O
induced	induced	O	O	O	O
and	and	O	O	O	O
that	that	O	O	O	O
cTnT	ctnt	O	O	O	O
should	should	O	O	O	O
be	be	O	O	O	O
a	a	O	O	O	O
useful	useful	O	O	O	O
marker	marker	O	O	O	O
for	for	O	O	O	O
the	the	O	O	O	O
prediction	prediction	O	O	O	O
of	of	O	O	O	O
experimentally	experimentally	O	O	O	O
induced	induced	O	O	O	O
cardiotoxicity	cardiotoxicity	O	DISEASE	OTHERS	I
and	and	O	O	O	O
possibly	possibly	O	O	O	O
for	for	O	O	O	O
cardioprotective	cardioprotective	O	O	O	O
experiments	experiments	O	O	O	O
.	.	O	O	O	O

